Mark I. Greene

(The Scientist, Vol:10 #6, p.8, March 18, 1996) MARK I. GREENE, John Eckman Professor of Medical Science, University of Pennsylvania, Philadelphia "THE SCIENTIST is an eclectic sounding board. It provides me with insight into, and information about, many different scientific disciplines." Mark Greene has been at the forefront of the fast-growing field of immunobiology and receptor research for the past 15 years. At the University of Pennsylvania's Cancer Center, Greene is currently working to

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

(The Scientist, Vol:10 #6, p.8, March 18, 1996)

MARK I. GREENE, John Eckman Professor of Medical Science, University of Pennsylvania, Philadelphia

"THE SCIENTIST is an eclectic sounding board. It provides me with insight into, and information about, many different scientific disciplines."

Mark Greene has been at the forefront of the fast-growing field of immunobiology and receptor research for the past 15 years. At the University of Pennsylvania's Cancer Center, Greene is currently working to define the principles by which certain receptor families, including the neu and EGF receptors, operate in causing cell growth and malignancy. Innovations unavailable 15 years ago have made possible recent gains in understanding receptor behavior. As an outgrowth of his research, Greene is using new immunologic techniques to design molecules that can turn receptors on and off, thereby preventing tumor development. He says: "We have made extraordinary, unexpected progress. What has helped us greatly is the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies